Main public logs
Jump to navigation
Jump to search
Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 20:18, 12 March 2024 Fire talk contribs created page Translations:Sitagliptin/3/ja (Created page with "<!-- Legal status --> | legal_AU = S4 | legal_AU_comment = | legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F --> | legal_BR_comment = | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_CA_comment = | legal_DE = <!-- Anlage I, II, III or Unscheduled --> | legal_DE_comment = | legal_NZ = <!-- Class A, B, C --> | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment...")
- 20:17, 12 March 2024 Fire talk contribs created page Translations:Sitagliptin/2/ja (Created page with "<!-- Clinical data --> | pronounce = {{IPAc-en|audio=En-us-Sitagliptin.ogg|s|ɪ|t|ə|ˈ|g|l|ɪ|p|t|ɪ|n}} | tradename = Januvia, Zituvio, others | Drugs.com = {{drugs.com|monograph|sitagliptin}} | MedlinePlus = a606023 | DailyMedID = Sitagliptin | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = 経口 | class = | ATC_prefix = A10 | ATC_suffix = BH01 | ATC_supplemental =")
- 20:17, 12 March 2024 Fire talk contribs created page Translations:Sitagliptin/1/ja (Created page with "{{Infobox drug | Watchedfields = changed | verifiedrevid = 464392221 | image = Sitagliptin.svg | width = 254 | alt = | image2 = Sitagliptin 3D.png | alt2 = | caption =")
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Sitagliptin/en (Updating to match new version of source page) Tags: Mobile edit Mobile web edit
- 20:17, 12 March 2024 Fire talk contribs created page Translations:Sitagliptin/Page display title/ja (Created page with "シタグリプチン")
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/23/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/22/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/21/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/20/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/19/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/18/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/17/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/16/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/15/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/14/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/13/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/12/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/11/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/10/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/9/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/8/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/7/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/6/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/5/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/4/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/3/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/2/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/1/en (Importing a new version from external source)
- 20:17, 12 March 2024 FuzzyBot talk contribs created page Translations:Sitagliptin/Page display title/en (Importing a new version from external source)
- 20:17, 12 March 2024 Fire talk contribs marked Sitagliptin for translation
- 20:17, 12 March 2024 Fire talk contribs limited languages for translatable page Sitagliptin to Japanese
- 20:15, 12 March 2024 Fire talk contribs created page Category:Triazoles (Created page with "{{Cat main|Triazole}} {{Commons cat|Triazoles}} Category:Azoles Category:Five-membered rings")
- 20:15, 12 March 2024 Fire talk contribs created page Category:Drugs developed by Merck & Co. (Created page with "{{Commonscat}} {{Cat main|Merck & Co.}} Category:Brands by company Category:Drug brand names Category:Health care brands Brands {{CatAutoTOC}}")
- 20:15, 12 March 2024 Fire talk contribs created page Category:Trifluoromethyl compounds (Created page with "{{Commons category|Trifluoromethyl compounds}} {{Cat main|Trifluoromethyl}} {{CatAutoTOC}} Category:Organofluorides")
- 20:14, 12 March 2024 Fire talk contribs created page Category:Drugboxes which contain changes to watched fields (Created page with "{{polluted category}} {{hidden category}} {{Chemical data validation}} This category contains pages which have been tagged by User:CheMoBot as having 'watched' fields which have been changed since the page has been verified (see Wikipedia:WikiProject Chemicals/Chembox validation). V Chemical data validation {{CatAutoTOC}}")
- 20:11, 12 March 2024 Fire talk contribs created page sitagliptin (Q21469) (wbeditentity-create:2|en: sitagliptin, chemical compound)
- 20:10, 12 March 2024 Fire talk contribs created page Template:Merck&Co/ja (Created page with "{{Navbox |name = Merck&Co/ja |title = Merck & Co., Inc. |state = {{{state|autocollapse}}} |bodyclass = hlist |group1 = 子会社 |list1 = * Acceleron Pharma * Cubist Pharmaceuticals * H. K. Mulford Company * Schering-Plough * Viralytics |group2 = 製品 |list2 = * アレンドロネート * Aprepitant/ja * Ertapenem/ja * Ezetimibe/ja * Ezetimibe/simvastatin/ja * Finasteride/ja * Fosaprepit...")
- 20:06, 12 March 2024 Fire talk contribs created page Template:Merck&Co (Created page with "{{Navbox |name = Merck&Co |title = Merck & Co., Inc. |state = {{{state|autocollapse}}} |bodyclass = hlist |group1 = Corporate directors |list1 = * Richard Clark * Johnnetta Cole * William Harrison * William Kelley * Rochelle Lazarus * Thomas Shenk * Anne Tatlock * Samuel Thier * Wendell Weeks * Peter Wendell |group2 = Subsidiaries |list2...")
- 20:05, 12 March 2024 Fire talk contribs created page Sitagliptin (Created page with "{{Short description|Diabetes medication}} {{Infobox drug | Watchedfields = changed | verifiedrevid = 464392221 | image = Sitagliptin.svg | width = 254 | alt = | image2 = Sitagliptin 3D.png | alt2 = | caption = <!-- Clinical data --> | pronounce = {{IPAc-en|audio=En-us-Sitagliptin.ogg|s|ɪ|t|ə|ˈ|g|l|ɪ|p|t|ɪ|n}} | tradename = Januvia, Zituvio, others | Drugs.com = {{drugs.com|monograph|sitagliptin}} | MedlinePlus = a606023 | DailyMedID = Sitagliptin | pregnancy_AU...")
- 19:59, 12 March 2024 Fire talk contribs created page Oral hypoglycemic/ja (Redirected page to 糖尿病治療薬) Tag: New redirect
- 19:59, 12 March 2024 Fire talk contribs created page Oral hypoglycemic (Redirected page to Diabetes medication) Tag: New redirect
- 19:57, 12 March 2024 Fire talk contribs created page Translations:Dipeptidyl peptidase-4 inhibitor/20/ja (Created page with "{{DEFAULTSORT:Dipeptidyl Peptidase-4 Inhibitor}} ")
- 19:57, 12 March 2024 Fire talk contribs created page Translations:Dipeptidyl peptidase-4 inhibitor/19/ja (Created page with "{{Oral hypoglycemics/ja}} {{Enzyme inhibition/ja}}")
- 19:57, 12 March 2024 Fire talk contribs created page Translations:Dipeptidyl peptidase-4 inhibitor/18/ja (Created page with "== こちらも参照 == * Development of dipeptidyl peptidase-4 inhibitors/ja")
- 19:57, 12 March 2024 Fire talk contribs created page Translations:Dipeptidyl peptidase-4 inhibitor/17/ja (Created page with "==併用薬物== {{Anchor|Combination drugs}} DPP-4阻害薬の中には、メトホルミンと併用することで相乗効果を発揮し、グルカゴン様ペプチド1（GLP-1）のレベルを上昇させ、肝の|グルコース産生を低下させる。")
- 19:56, 12 March 2024 Fire talk contribs created page Translations:Dipeptidyl peptidase-4 inhibitor/16/ja (Created page with "2014年のメタアナリシスでは、DPP-4阻害薬で治療された患者における膵臓がんリスク増加のエビデンスは認められなかったが、入手可能なデータ量が少ないため、可能性のあるリスクを完全に除外することはできなかった。")
- 19:56, 12 March 2024 Fire talk contribs created page Translations:Biguanide/16/ja (Created page with "====副作用と毒性==== 最も一般的な副作用は下痢と消化不良であり、患者の最大30％に発現する。 最も重要で重篤な副作用は乳酸アシドーシスであるため、メトホルミンは進行した慢性腎臓病では禁忌である。メトホルミンを開始する前に腎機能を評価すべきである。フェンホルミンとブホルミンはメト...")
- 19:55, 12 March 2024 Fire talk contribs created page Translations:Dipeptidyl peptidase-4 inhibitor/15/ja (Created page with "===癌=== DPP-4阻害薬シタグリプチンを投与されたラットおよび臓器提供者の膵臓に前癌性変化がみられたという報告を受けて、米国FDAと欧州医薬品庁はそれぞれ、DPP-4阻害薬と膵癌との関連の可能性に関するすべての臨床および前臨床データの独立したレビューを行った。ニューイングランド・ジャーナル・オブ・メディシン誌への共同書簡の中で、両機...")
- 19:54, 12 March 2024 Fire talk contribs created page Translations:Biguanide/15/ja (Created page with "ビグアナイドは銅と相互作用することが示されており、特にミトコンドリアでは、2+酸化状態の銅（Cu(II)）をキレート化することによって、細胞の代謝を阻害する。")
- 19:53, 12 March 2024 Fire talk contribs created page Translations:Dipeptidyl peptidase-4 inhibitor/14/ja (Created page with "2020年のコクラン系統的レビューでは、2型糖尿病の治療においてメトホルミン単剤療法とジペプチジルペプチダーゼ-4阻害薬を比較した場合、全死亡、重篤な有害事象、心血管死亡、非致死的心筋梗塞、非致死的脳卒中、または末期腎疾患の減少を示す十分なエビデンスは認められなかっ...")